137 related articles for article (PubMed ID: 15896782)
1. Constitutive dimerization of human serotonin 5-HT4 receptors in living cells.
Berthouze M; Ayoub M; Russo O; Rivail L; Sicsic S; Fischmeister R; Berque-Bestel I; Jockers R; Lezoualc'h F
FEBS Lett; 2005 Jun; 579(14):2973-80. PubMed ID: 15896782
[TBL] [Abstract][Full Text] [Related]
2. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain.
Claeysen S; Sebben M; Becamel C; Bockaert J; Dumuis A
Mol Pharmacol; 1999 May; 55(5):910-20. PubMed ID: 10220570
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
[TBL] [Abstract][Full Text] [Related]
4. Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization.
Berthouze M; Rivail L; Lucas A; Ayoub MA; Russo O; Sicsic S; Fischmeister R; Berque-Bestel I; Jockers R; Lezoualc'h F
Biochem Biophys Res Commun; 2007 May; 356(3):642-7. PubMed ID: 17379184
[TBL] [Abstract][Full Text] [Related]
5. New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting.
Joubert L; Hanson B; Barthet G; Sebben M; Claeysen S; Hong W; Marin P; Dumuis A; Bockaert J
J Cell Sci; 2004 Oct; 117(Pt 22):5367-79. PubMed ID: 15466885
[TBL] [Abstract][Full Text] [Related]
6. Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.
Castro L; Mialet-Perez J; Guillemeau A; Stillitano F; Zolk O; Eschenhagen T; Lezoualc'h F; Bochet P; Fischmeister R
J Mol Cell Cardiol; 2005 Aug; 39(2):335-44. PubMed ID: 15950987
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.
Herrick-Davis K; Grinde E; Mazurkiewicz JE
Biochemistry; 2004 Nov; 43(44):13963-71. PubMed ID: 15518545
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional effects of human 5-HT4 receptor isoforms on beta-amyloid secretion.
Robert SJ; Lezoualc'h F
Neurodegener Dis; 2008; 5(3-4):163-5. PubMed ID: 18322379
[TBL] [Abstract][Full Text] [Related]
10. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
11. Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k.
De Martelaere K; Lintermans B; Haegeman G; Vanhoenacker P
Cell Signal; 2007 Feb; 19(2):278-88. PubMed ID: 16935469
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin receptors form constitutive homo- and heterodimers.
Mandrika I; Petrovska R; Wikberg J
Biochem Biophys Res Commun; 2005 Jan; 326(2):349-54. PubMed ID: 15582585
[TBL] [Abstract][Full Text] [Related]
13. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor.
Leung PK; Chow KB; Lau PN; Chu KM; Chan CB; Cheng CH; Wise H
Cell Signal; 2007 May; 19(5):1011-22. PubMed ID: 17229547
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
Mialet J; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor.
van Rijn RM; van Marle A; Chazot PL; Langemeijer E; Qin Y; Shenton FC; Lim HD; Zuiderveld OP; Sansuk K; Dy M; Smit MJ; Tensen CP; Bakker RA; Leurs R
Biochem J; 2008 Aug; 414(1):121-31. PubMed ID: 18452403
[TBL] [Abstract][Full Text] [Related]
17. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
18. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Brüss M; Bönisch H; Bühlen M; Nöthen MM; Propping P; Göthert M
Pharmacogenetics; 1999 Feb; 9(1):95-102. PubMed ID: 10208648
[TBL] [Abstract][Full Text] [Related]
19. Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor.
Krishnaveni MS; Hansen JL; Seeger W; Morty RE; Sheikh SP; Eickelberg O
Biochem Biophys Res Commun; 2006 Dec; 351(3):651-7. PubMed ID: 17078931
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
